Columbia University CUIMC/NYPH — New York, New York

Columbia University CUIMC/NYPH is a clinical research site located in New York, New York, United States 10032.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

Columbia University CUIMC/NYPH has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Unresectable Hepatocellular Carcinoma, BCLC Stage A Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma.

Sponsors: Sirtex Medical.

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Columbia University CUIMC/NYPH?

Columbia University CUIMC/NYPH has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Columbia University CUIMC/NYPH conducted?

Columbia University CUIMC/NYPH has 1 clinical trials on record, with 1 currently active. Their work covers Unresectable Hepatocellular Carcinoma, BCLC Stage A Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma.

Is Columbia University CUIMC/NYPH accredited by Crixeo Health?

Columbia University CUIMC/NYPH has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Columbia University CUIMC/NYPH?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.